Cargando…
Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis
OBJECTIVES: To examine company characteristics associated with better transparency and to apply a tool used to measure and improve clinical trial transparency among large companies and drugs, to smaller companies and biologics. DESIGN: Cross-sectional descriptive analysis. SETTING AND PARTICIPANTS:...
Autores principales: | Axson, Sydney A, Mello, Michelle M, Lincow, Deborah, Yang, Catherine, Gross, Cary P, Ross, Joseph S, Miller, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291313/ https://www.ncbi.nlm.nih.gov/pubmed/34281933 http://dx.doi.org/10.1136/bmjopen-2021-053248 |
Ejemplares similares
-
Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies
por: Miller, Jennifer E, et al.
Publicado: (2017) -
Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices
por: Miller, Jennifer, et al.
Publicado: (2019) -
Impact of China's Vaccine Incidents on the Operational Efficiency of Biopharmaceutical Companies
por: Chai, Kuang-Cheng, et al.
Publicado: (2020) -
Recommendations for the ethical conduct of vaccination awareness campaigns by biopharmaceutical companies
por: van der Zee, Claar, et al.
Publicado: (2022) -
Medical Research Charities and Biopharmaceutical Companies as Partners in Patient-Centred R&D
por: Flatau, Tina, et al.
Publicado: (2022)